{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T03:47:16Z","timestamp":1743133636409,"version":"3.40.3"},"publisher-location":"New York, NY","reference-count":27,"publisher":"Springer US","isbn-type":[{"type":"print","value":"9781071626504"},{"type":"electronic","value":"9781071626511"}],"license":[{"start":{"date-parts":[[2022,12,9]],"date-time":"2022-12-09T00:00:00Z","timestamp":1670544000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,12,9]],"date-time":"2022-12-09T00:00:00Z","timestamp":1670544000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023]]},"DOI":"10.1007\/978-1-0716-2651-1_8","type":"book-chapter","created":{"date-parts":[[2022,12,8]],"date-time":"2022-12-08T19:08:04Z","timestamp":1670526484000},"page":"91-100","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The Use of Optical Coherence Tomography in Evaluation of Retinitis Pigmentosa"],"prefix":"10.1007","author":[{"given":"Ha Min","family":"Kim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin Kyun","family":"Oh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen H.","family":"Tsang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,12,9]]},"reference":[{"key":"8_CR1","doi-asserted-by":"publisher","first-page":"OCT1","DOI":"10.1167\/iovs.16-19963","volume":"57","author":"J Fujimoto","year":"2016","unstructured":"Fujimoto J, Swanson E (2016) The development, commercialization, and impact of optical coherence tomography. Investig Ophthalmol Vis Sci 57:OCT1\u2013OCT13","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"8_CR2","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1126\/science.1957169","volume":"254","author":"D Huang","year":"1991","unstructured":"Huang D, Swanson EA, Lin CP et al (1991) Optical coherence tomography. Science 254:1178\u20131181","journal-title":"Science"},{"key":"8_CR3","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1364\/OE.11.000889","volume":"11","author":"R Leitgeb","year":"2003","unstructured":"Leitgeb R, Hitzenberger C, Fercher A (2003) Performance of fourier domain vs time domain optical coherence tomography. Opt Express 11:889","journal-title":"Opt Express"},{"key":"8_CR4","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1117\/1.1482379","volume":"7","author":"M Wojtkowski","year":"2002","unstructured":"Wojtkowski M, Leitgeb R, Kowalczyk A et al (2002) In vivo human retinal imaging by Fourier domain optical coherence tomography. J Biomed Opt 7:457","journal-title":"J Biomed Opt"},{"key":"8_CR5","doi-asserted-by":"publisher","first-page":"S6","DOI":"10.2144\/000112090","volume":"39","author":"Z Yaqoob","year":"2005","unstructured":"Yaqoob Z, Wu J, Yang C (2005) Spectral domain optical coherence tomography: a better OCT imaging strategy. BioTechniques 39:S6\u2013S13","journal-title":"BioTechniques"},{"key":"8_CR6","doi-asserted-by":"publisher","unstructured":"Theelen T, Teussink MM (2018) Inspection of the human retina by optical coherence tomography. In: Boon C, Wijnholds J (eds) Retinal gene therapy. Methods in Molecular Biology, vol 1715. Humana Press, New York, NY. https:\/\/doi.org\/10.1007\/978-1-4939-7522-8_26","DOI":"10.1007\/978-1-4939-7522-8_26"},{"key":"8_CR7","doi-asserted-by":"publisher","DOI":"10.1117\/1.2793736","volume":"12","author":"AM Zysk","year":"2007","unstructured":"Zysk AM, Nguyen FT, Oldenburg AL et al (2007) Optical coherence tomography: a review of clinical development from bench to bedside. J Biomed Opt 12:051403","journal-title":"J Biomed Opt"},{"key":"8_CR8","doi-asserted-by":"crossref","unstructured":"Tsang SH and Sharma T (2018) Optical coherence tomography BT - atlas of inherited retinal diseases, presented at the","DOI":"10.1007\/978-3-319-95046-4"},{"key":"8_CR9","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1097\/APO.0000000000000227","volume":"5","author":"Q Zhang","year":"2016","unstructured":"Zhang Q (2016) Retinitis pigmentosa. Asia-Pacific J Ophthalmol 5:265\u2013271","journal-title":"Asia-Pacific J Ophthalmol"},{"key":"8_CR10","doi-asserted-by":"publisher","first-page":"4213","DOI":"10.1167\/iovs.09-4945","volume":"51","author":"NV Rangaswamy","year":"2010","unstructured":"Rangaswamy NV, Patel HM, Locke KG et al (2010) A comparison of visual field sensitivity to photoreceptor thickness in retinitis pigmentosa. Invest Opthalmol Vis Sci 51:4213","journal-title":"Invest Opthalmol Vis Sci"},{"key":"8_CR11","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1167\/tvst.2.7.5","volume":"2","author":"R Ramachandran","year":"2013","unstructured":"Ramachandran R, Zhou L, Locke KG et al (2013) A comparison of methods for tracking progression in X-linked retinitis pigmentosa using frequency domain OCT. Transl Vis Sci Technol 2:5","journal-title":"Transl Vis Sci Technol"},{"key":"8_CR12","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1001\/jamaophthalmol.2016.0502","volume":"134","author":"AH Hariri","year":"2016","unstructured":"Hariri AH, Zhang HY, Ho A et al (2016) Quantification of ellipsoid zone changes in retinitis pigmentosa using en face spectral domain-optical coherence tomography. JAMA Ophthalmol 134:628\u2013635","journal-title":"JAMA Ophthalmol"},{"issue":"4","key":"8_CR13","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1016\/j.ajo.2015.06.032","volume":"160","author":"T Sujirakul","year":"2015","unstructured":"Sujirakul T, Lin MK, Duong J, Wei Y, Lopez-Pintado S, Tsang SH (2015) Multimodal imaging of central retinal disease progression in a 2-year mean follow-up of retinitis pigmentosa. Am J Ophthalmol 160(4):786\u2013798 e784","journal-title":"Am J Ophthalmol"},{"key":"8_CR14","doi-asserted-by":"crossref","unstructured":"Cabral T, Lima de Carvalho JR Jr, Kim J, Oh JK, Levi SR, Park KS, Duong JK, Park J, Boudreault K, Belfort R Jr, Tsang SH (2020) Comparative analysis of functional and structural decline in retinitis pigmentosas. Int J Mol Sci 21(8)","DOI":"10.3390\/ijms21082730"},{"issue":"9","key":"8_CR15","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1001\/jamaophthalmol.2013.4160","volume":"131","author":"DG Birch","year":"2013","unstructured":"Birch DG, Locke KG, Wen Y, Locke KI, Hoffman DR, Hood DC (2013) Spectral-domain optical coherence tomography measures of outer segment layer progression in patients with X-linked retinitis pigmentosa. JAMA Ophthalmol 131(9):1143\u20131150","journal-title":"JAMA Ophthalmol"},{"key":"8_CR16","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1364\/BOE.2.001106","volume":"2","author":"DC Hood","year":"2011","unstructured":"Hood DC, Ramachandran R, Holopigian K et al (2011) Method for deriving visual field boundaries from OCT scans of patients with retinitis pigmentosa. Biomed Opt Express 2:1106","journal-title":"Biomed Opt Express"},{"issue":"1","key":"8_CR17","doi-asserted-by":"publisher","first-page":"10712","DOI":"10.1038\/s41598-019-47251-z","volume":"9","author":"R Jauregui","year":"2019","unstructured":"Jauregui R, Takahashi VKL, Park KS, Cui X, Takiuti JT, Lima de Carvalho JR Jr, Tsang SH (2019) Multimodal structural disease progression of retinitis pigmentosa according to mode of inheritance. Sci Rep 9(1):10712","journal-title":"Sci Rep"},{"issue":"7","key":"8_CR18","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1001\/archopht.1978.03910060019004","volume":"96","author":"GA Fishman","year":"1978","unstructured":"Fishman GA (1978) Retinitis pigmentosa. Visual loss. Arch Ophthalmol 96(7):1185\u20131188","journal-title":"Arch Ophthalmol"},{"issue":"3","key":"8_CR19","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1001\/archopht.1988.01060130395029","volume":"106","author":"GA Fishman","year":"1988","unstructured":"Fishman GA, Farber MD, Derlacki DJ (1988) X-linked retinitis pigmentosa. Profile of clinical findings. Arch Ophthalmol 106(3):369\u2013375","journal-title":"Arch Ophthalmol"},{"key":"8_CR20","doi-asserted-by":"publisher","first-page":"a004481","DOI":"10.1101\/mcs.a004481","volume":"5","author":"SD Ragi","year":"2019","unstructured":"Ragi SD, De Carvalho JRL, Tanaka AJ et al (2019) Compound heterozygous novel frameshift variants in the PROM1 gene result in Leber congenital amaurosis. Cold Spring Harb Mol Case Stud 5:a004481","journal-title":"Cold Spring Harb Mol Case Stud"},{"key":"8_CR21","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1159\/000445063","volume":"56","author":"G Liu","year":"2016","unstructured":"Liu G, Liu X, Li H et al (2016) Optical coherence tomographic analysis of retina in retinitis pigmentosa patients. Ophthalmic Res 56:111\u2013122","journal-title":"Ophthalmic Res"},{"key":"8_CR22","doi-asserted-by":"publisher","first-page":"2328","DOI":"10.1167\/iovs.08-2936","volume":"50","author":"DC Hood","year":"2009","unstructured":"Hood DC, Lin CE, Lazow MA et al (2009) Thickness of receptor and post-receptor retinal layers in patients with retinitis pigmentosa measured with frequency-domain optical coherence tomography. Investig Ophthalmol Vis Sci 50:2328\u20132336","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"8_CR23","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1167\/iovs.10-5799","volume":"52","author":"DC Hood","year":"2011","unstructured":"Hood DC, Lazow MA, Locke KG et al (2011) The transition zone between healthy and diseased retina in patients with retinitis pigmentosa. Invest Ophthalmol Vis Sci 52:101","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"8_CR24","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.exer.2013.05.003","volume":"113","author":"JH Acton","year":"2013","unstructured":"Acton JH, Greenberg JP, Greenstein VC et al (2013) Evaluation of multimodal imaging in carriers of X-linked retinitis pigmentosa. Exp Eye Res 113:41\u201348","journal-title":"Exp Eye Res"},{"issue":"4","key":"8_CR25","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1001\/archopht.1997.01100150513011","volume":"115","author":"A Santos","year":"1997","unstructured":"Santos A, Humayun MS, de Juan E Jr, Greenburg RJ, Marsh MJ, Klock IB, Milam AH (1997) Preservation of the inner retina in retinitis pigmentosa. A morphometric analysis. Arch Ophthalmol 115(4):511\u2013515","journal-title":"Arch Ophthalmol"},{"issue":"1","key":"8_CR26","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1159\/000342159","volume":"229","author":"G Coscas","year":"2013","unstructured":"Coscas G, De Benedetto U, Coscas F, Li Calzi CI, Vismara S, Roudot-Thoraval F, Bandello F, Souied E (2013) Hyperreflective dots: a new spectral-domain optical coherence tomography entity for follow-up and prognosis in exudative age-related macular degeneration. Ophthalmologica 229(1):32\u201337","journal-title":"Ophthalmologica"},{"key":"8_CR27","doi-asserted-by":"publisher","first-page":"435","DOI":"10.2147\/OPTH.S58164","volume":"8","author":"M Kuroda","year":"2014","unstructured":"Kuroda M, Hirami Y, Hata M et al (2014) Intraretinal hyperreflective foci on spectral-domain optical coherence tomographic images of patients with retinitis pigmentosa. Clin Ophthalmol 8:435\u2013440","journal-title":"Clin Ophthalmol"}],"container-title":["Methods in Molecular Biology","Retinitis Pigmentosa"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-0716-2651-1_8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,21]],"date-time":"2023-01-21T03:58:20Z","timestamp":1674273500000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-0716-2651-1_8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,9]]},"ISBN":["9781071626504","9781071626511"],"references-count":27,"URL":"https:\/\/doi.org\/10.1007\/978-1-0716-2651-1_8","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"type":"print","value":"1064-3745"},{"type":"electronic","value":"1940-6029"}],"subject":[],"published":{"date-parts":[[2022,12,9]]},"assertion":[{"value":"9 December 2022","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}},{"value":"Stephen H. Tsang receives financial support from Abeona Therapeutics, Inc and Emendo. He is also the founder of Rejuvitas and is on the scientific and clinical advisory board for Nanoscope Therapeutics.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of Interest"}}]}}